エピソード

  • Why Radiopharmaceuticals? Scientific Promise + Market Momentum | Ep 1

    Why Radiopharmaceuticals? Scientific Promise + Market Momentum | Ep 1
    2026/07/20
    Radiopharmaceuticals are generating significant excitement across oncology, offering a highly targeted approach that combines precision medicine with the power of radiation. In this opening episode of Radiopharmaceutical Trials: An Operational Playbook, the discussion explores why these therapies are attracting growing attention from sponsors, researchers, clinicians, and investors alike, and what is driving their rapid momentum across the drug development landscape. Host Hector Herrero is joined by Dr. Kavi Karra and Dr. Paulo Nunes to examine both the scientific promise and the operational realities of radiopharmaceutical development. Together, they discuss how radiopharmaceutical trials differ from traditional oncology studies, from specialized site requirements and radiation safety considerations to the complex coordination needed across clinical, manufacturing, and logistics teams. Host: Hector Herrero, Senior Director on Global Project Management at Fortrea Participants: Dr. Kavi Karra, Senior Medical Director GE HealthCare and Dr. Paulo Nunes, Medical Director at Fortrea
    続きを読む 一部表示
    19 分
  • Timing Is Everything: The Importance of Logistics in Radiopharmaceutical Trials | Ep 2

    Timing Is Everything: The Importance of Logistics in Radiopharmaceutical Trials | Ep 2
    2026/07/20
    This episode of Radiopharmaceutical Trials: An Operational Playbook explores why logistics isn’t just a support function in radiopharmaceutical trials—it’s often the deciding factor in whether treatment can happen at all. From managing ultra-short half-lives to understanding the real impact of even small delays, it unpacks five critical questions shaping this high-stakes field. Featuring expert perspectives, the conversation highlights the precision, pressure, and patient impact behind radiopharma logistics. Host: Hector Herrero, Senior Director on Global Project Management at Fortrea Participant: Graham McCarthy, MIAS Pharma
    続きを読む 一部表示
    18 分
  • Radiopharmaceuticals Manufacturing & Distribution Constraints: When Precision Meets Pressure | Ep 3

    Radiopharmaceuticals Manufacturing & Distribution Constraints: When Precision Meets Pressure | Ep 3
    2026/07/20
    This episode of Radiopharmaceutical Trials: An Operational Playbook takes a closer look at the critical role of manufacturing, quality release, and cross-border distribution in radiopharmaceutical trials—where every minute counts. It explores the operational complexity of producing and delivering treatments under extreme time constraints and strict regulatory controls. The conversation highlights how precision at every step directly impacts whether patients can receive their dose on time. Host: Hector Herrero, Senior Director on Global Project Management at Fortrea Participant: Graham McCarthy, MIAS Pharma
    続きを読む 一部表示
    11 分
  • Choosing the Right Sites

    Choosing the Right Sites
    2026/08/18
    Radiopharmaceuticals are reshaping the oncology landscape, combining targeted therapy with precision radiation in ways that are generating growing interest across sponsors, researchers, and clinical teams. But behind the promise lies a uniquely complex trial environment — one that demands specialized infrastructure, tightly coordinated logistics, and deep operational expertise. In Radiopharmaceutical Trials: The Operational Playbook, Fortrea along with industry specialists unpack the critical factors that can influence study success, from site selection and feasibility to supply chain timing, manufacturing, and distribution. Designed for biotech and biopharma teams navigating this evolving space, the series offers practical insight into what it takes to execute radiopharmaceutical trials with confidence.
    続きを読む 一部表示
    17 分
  • The Challenge of Site Readiness

    The Challenge of Site Readiness
    2026/08/18
    Operationally, radiopharmaceutical studies behave differently than more traditional oncology studies. We are talking not only about site capability to handle radiopharmaceuticals or having a license for the specific radioisotope, but also having been trained on the study specifics, or calibrating the instruments. To explore this from the clinical perspective, we are joined by Dr. Cristina Matsushita and Dr. Paolo Nunes, oncologist and senior medical director at Fortrea, with extensive hands-on experience conducting pharmaceutical clinical trials.
    続きを読む 一部表示
    17 分